Harvard Bioscience, Inc. (NASDAQ:HBIO)

CAPS Rating: 4 out of 5

A developer, manufacturer and marketer of a range of specialized products, primarily apparatus and scientific instruments, used to improve life science research at pharmaceutical & biotechnology companies, universities & government laboratories worldwide.

Recs

1
Player Avatar surabayajhonny (60.30) Submitted: 1/25/2013 2:22:08 AM : Outperform Start Price: $3.60 HBIO Score: +0.39

Jim Royal

Featured Broker Partners


Advertisement